REGN

REGN

Regeneron Pharmaceuticals Inc
Biotechnology
$638.88 -0.58% As of May 26, 12:50 AM
Loading chart...
Interactive chart powered by TradingView

Technical Analysis

Bears Tighten Grip on REGN Below $638.88

Bearish
May 26, 2026 at 12:50 AM • $638.88 (-0.58%)

The stock of Regeneron Pharmaceuticals Inc (REGN) dropped 0.58% to close at $638.88 on May 26.

Chart analysis reveals a bearish configuration:

Momentum RSI at 31.1 is in neutral territory but trending higher. MACD is bearish (-25.96 vs signal -19.17).
Moving Averages Moving averages are stacked bearishly—price below the 9-day at $663.50, resistance at 21-day ($690.73).
Volatility Bollinger Band width at 20.0% indicates normal volatility.

While EMAs remain bearish, the oversold RSI reading hints at potential support around $624.95.

Key levels to watch: Support at $624.95, Resistance at $763.64.

REGN Bears Take Control as Stock Slides to $638.88

Bearish
May 25, 2026 at 9:01 PM • $638.88 (-0.58%)

Moving Average Resistance Caps REGN at $638.88

Bearish
May 24, 2026 at 12:12 AM • $638.88 (-0.58%)

REGN Breaks Down Through EMAs to $638.88

Bearish
May 23, 2026 at 5:16 AM • $638.88 (-0.58%)

EMA Death Cross Looms for REGN Near $638.88

Bearish
May 22, 2026 at 9:01 PM • $638.88 (-0.58%)
Systematic technical analysis • Updated daily after market close
Exclusive Offer

Get Trade Alerts

Receive disciplined options trade ideas with entries, targets & risk management.

Use code:
HEADSTART50
50% off your first month
Claim Offer Try Scanner

Market Summary

Current Price $638.88
Daily Change -0.58%
Sentiment Bearish
Sector Biotechnology
Last Updated May 26

Related Stocks

ABBV
ABBV
AbbVie Inc
AMGN
AMGN
Amgen Inc
BIIB
BIIB
Biogen Inc
MRNA
MRNA
Moderna Inc
VRTX
VRTX
Vertex Pharmaceuticals Inc
Disclaimer: This analysis is for educational purposes only. Options trading involves substantial risk. Past performance does not guarantee future results.